218 related articles for article (PubMed ID: 37545707)
1.
Nascimento-Gonçalves E; Seixas F; Ferreira R; Oliveira PA; Colaço B
Open Vet J; 2023 Jun; 13(6):782-793. PubMed ID: 37545707
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer in dogs: comparative and clinical aspects.
Leroy BE; Northrup N
Vet J; 2009 May; 180(2):149-62. PubMed ID: 18786842
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases.
Cornell KK; Bostwick DG; Cooley DM; Hall G; Harvey HJ; Hendrick MJ; Pauli BU; Render JA; Stoica G; Sweet DC; Waters DJ
Prostate; 2000 Oct; 45(2):173-83. PubMed ID: 11027417
[TBL] [Abstract][Full Text] [Related]
4. Comparative pathology of dog and human prostate cancer.
Ryman-Tubb T; Lothion-Roy JH; Metzler VM; Harris AE; Robinson BD; Rizvanov AA; Jeyapalan JN; James VH; England G; Rutland CS; Persson JL; Kenner L; Rubin MA; Mongan NP; de Brot S
Vet Med Sci; 2022 Jan; 8(1):110-120. PubMed ID: 34628719
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. What is your diagnosis? Prostate neoplasm with metastases to bone.
Schkeeper AE; Foss K; Drost WT
J Am Vet Med Assoc; 2013 Aug; 243(4):483-5. PubMed ID: 23902439
[No Abstract] [Full Text] [Related]
7. Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.
Anidjar M; Scarlata E; Cury FL; Rocha J; Hamel L; Luz M; Chevalier S
Prostate; 2012 May; 72(7):752-61. PubMed ID: 21882212
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
9. Animal models of bone metastasis.
Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
[TBL] [Abstract][Full Text] [Related]
10. Prostatic adenocarcinoma with osseous metastases in a dog.
Lee-Parritz DE; Lamb CR
J Am Vet Med Assoc; 1988 Jun; 192(11):1569-72. PubMed ID: 3045059
[TBL] [Abstract][Full Text] [Related]
11. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
12. Skeletal metastasis as the initial clinical manifestation of metastatic carcinoma in 19 dogs.
Cooley DM; Waters DJ
J Vet Intern Med; 1998; 12(4):288-93. PubMed ID: 9686389
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.
Palmieri C
Vet Pathol; 2015 Jul; 52(4):607-13. PubMed ID: 25281650
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Models of Prostate Cancer: Their Contribution to Current Therapies.
Faustino-Rocha AI; Jota-Baptista C; Nascimento-Gonçalves E; Oliveira PA
Anticancer Res; 2023 Jan; 43(1):323-333. PubMed ID: 36585171
[TBL] [Abstract][Full Text] [Related]
16. Prostatic adenocarcinoma with and without metastasis to bone in dogs.
Durham SK; Dietze AE
J Am Vet Med Assoc; 1986 Jun; 188(12):1432-6. PubMed ID: 3744970
[TBL] [Abstract][Full Text] [Related]
17. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.
Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM
BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179
[TBL] [Abstract][Full Text] [Related]
18. High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer.
Aquilina JW; McKinney L; Pacelli A; Richman LK; Waters DJ; Thompson I; Burghardt WF; Bostwick DG
Prostate; 1998 Aug; 36(3):189-93. PubMed ID: 9687991
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer in dogs and men: a unique opportunity to study the disease.
Argyle DJ
Vet J; 2009 May; 180(2):137-8. PubMed ID: 18835203
[No Abstract] [Full Text] [Related]
20. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
